BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1511 related articles for article (PubMed ID: 32446778)

  • 1. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
    Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
    Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
    Zhang YY; Li BR; Ning BT
    Front Immunol; 2020; 11():2033. PubMed ID: 32922406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in".
    Castelli V; Cimini A; Ferri C
    Front Immunol; 2020; 11():2132. PubMed ID: 32983172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19: Perspectives on Innate Immune Evasion.
    Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
    Front Immunol; 2020; 11():580641. PubMed ID: 33101306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines and COVID-19: friends or foes?
    Rokni M; Hamblin MR; Rezaei N
    Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COVID-19 Cytokine Storm; What We Know So Far.
    Ragab D; Salah Eldin H; Taeimah M; Khattab R; Salem R
    Front Immunol; 2020; 11():1446. PubMed ID: 32612617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
    Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
    Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
    Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
    Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection-induced immune responses: Friends or foes?
    Li K; Hao Z; Zhao X; Du J; Zhou Y
    Scand J Immunol; 2020 Aug; 92(2):e12895. PubMed ID: 32445403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine storm intervention in the early stages of COVID-19 pneumonia.
    Sun X; Wang T; Cai D; Hu Z; Chen J; Liao H; Zhi L; Wei H; Zhang Z; Qiu Y; Wang J; Wang A
    Cytokine Growth Factor Rev; 2020 Jun; 53():38-42. PubMed ID: 32360420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Inflammasome in Times of COVID-19.
    de Rivero Vaccari JC; Dietrich WD; Keane RW; de Rivero Vaccari JP
    Front Immunol; 2020; 11():583373. PubMed ID: 33149733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.
    Karmouty-Quintana H; Thandavarayan RA; Keller SP; Sahay S; Pandit LM; Akkanti B
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.
    Johnson BS; Laloraya M
    Cytokine Growth Factor Rev; 2020 Aug; 54():32-42. PubMed ID: 32747157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe COVID-19: what have we learned with the immunopathogenesis?
    Bordallo B; Bellas M; Cortez AF; Vieira M; Pinheiro M
    Adv Rheumatol; 2020 Sep; 60(1):50. PubMed ID: 32962761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine Storms: Understanding COVID-19.
    Mangalmurti N; Hunter CA
    Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.
    Polidoro RB; Hagan RS; de Santis Santiago R; Schmidt NW
    Front Immunol; 2020; 11():1626. PubMed ID: 32714336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.